Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 406

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 406
---
. The Class I Directors stand appointed for a term expiring at Denali’s first annual general meeting, the Class II Directors stand appointed for a term expiring at our second annual general meeting and the Class III Directors stand appointed for a term expiring at our third annual general meeting. Commencing at the first annual general meeting, and at each annual general meeting thereafter, directors appointed to succeed those directors whose terms expire are appointed for a term of office to expire at the third succeeding annual general meeting after their appointment. Except as applicable law may otherwise require, in the interim between annual general meetings or extraordinary general meetings called for the appointment of directors and/or the removal of one or more directors and the filling of any vacancy, additional directors and any vacancies in the board of directors, including unfilled vacancies resulting from the removal of directors for cause, may be filled by the vote of a majority of the remaining directors then in office, even though a quorum may not be present at any meeting of the directors, or by the sole remaining director. All directors hold office until the expiration of their respective terms of office and until their successors have been appointed. A director appointed to fill a vacancy resulting from the death, resignation or removal of a director serves for the remainder of the full term of the director whose death, resignation or removal has created the vacancy and until his successor has been appointed. It is proposed that the New Semnur Board will consist of the following directors:

| • |     | Class I director: Jay Chun, M.D., Ph.D. and such director’s term will expire at the annual meeting of 
 stockholders to be held in 2025;                                                                      |

| • |     | Class II directors: Dorman Followwill and Yue Alexander Wu, Ph.D. and their terms will expire at the annual 
 meeting of stockholders to be held in 2026; and                                                             |

| • |     | Class III directors: Henry Ji, Ph.D. and Jaisim Shah and their terms will expire at the annual meeting of 
 stockholders to be held in 2027.                                                                          |

Information regarding each nominee is set forth in the section titled “ Directors and Executive Officers of New Semnur After the Business Combination.” Vote Required for Approval The election of each director requires an ordinary resolution under Cayman Islands law, being the affirmative vote of the majority of the Denali Ordinary Shares present in person or represented by proxy and entitled to vote thereon and who vote at the Meeting or any adjournment or postponement thereof. In